Skip to main content
OpenTrials
Completed

NCT Number: NCT07371949

CHRONO-NUTRITION APPLICATION: THE EFFECT OF FIBER JELLY ON POST PRANDIAL BLOOD GLUCOSE, SATIETY AND WEIGHT LOSS AMONG OVERWEIGHT WOMEN

The goal of this observational study is to learn about the effects of pre meal fiber jelly in overweight women over the age of 20-60 who take intervention pre meal fiber jelly on their postprandial blood glucose level and appetite level.

The main question it aims to answer is:

Does pre meal fiber jelly in overweight women effect on their postprandial blood glucose level and appetite level?

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Sports and Health Sciences

Surabaya, Indonesia, 60213

About this study

Prior to the test days, participants were asked to fast overnight following the standard procedure for fasting blood glucose measurement. Additionally, participants were asked to refrain from vigorous physical activity prior to the test days. On the test days, fasting blood glucose was taken prior to the breakfast test meal at 0 minute. Then, participants were asked to consume fibre jelly for those in the intervention group and carrageenan-based jelly for those in the control group. After consuming jelly, participants from both groups were asked to consume bread, which was equal to 50 grams of starch and 250 ml of water in 10 minutes. To measure their postprandial blood glucose levels, participants were required to fast for the next 2 hours. After blood samples were collected, participants were provided with a complete meal and unlimited water. Participants were allowed to eat and drink as much as they desire following their satiety and hunger cues (ad-libitum). The remaining foods were weighed to calculate the total calories consumed by participants.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(1) female adults aged between 20-60 years; (2) having fasting blood glucose level <125 mg/dL; (3) having body mass index (BMI) more than or equal to 23; (4) not undergoing loss weight program during the recruitment process; (5) not allergic to rosella and basil seed

Exclusion criteria

Candidates were excluded if they were pregnant or lactating, had any medical conditions, including gastrointestinal disorders, cardiovascular disease, or other chronic diseases, smoking, or consuming alcohol.

Treatment and study plan

Fiber jelly

Combination Product

Fibre jelly was formulated using basil seeds, psyllium husk, rosella water extract, and carrageenan, while the control jelly was formulated using water and carrageenan as a gelling agent. Both types of jelly contained the same amount of stevia and fructose as sweeteners. Fibre jelly contained approximately 7.89 g of fibre in each pouch (~100 g).

Other names: Intervention

Primary outcomes

  1. Blood Glucose level

    Time frame: 0, 30, 45, 60, 90, 120 minute

    Post prandial blood glucose level

  2. Appetite level

    Time frame: 0 minute, 30 minute, 45 minute, 60 minute, 90 minute, 120 minute, 180 minute, 240 minute

    Visual analog scale of hunger, fullness, appetite, prospective food, and satisfaction

Sponsors and collaborators

Lead sponsor

Surabaya State University

Other

Registry information

Official study title

APLIKASI CHRONO- NUTRITION : PENGARUH FIBER JELLY TERHADAP RESPON GLUKOSA DARAH, KEKENYANGAN POST PRANDIAL, DAN WEIGH LOSS PADA WANITA OVERWEIGHT"

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jan 28, 2026
Registry last updated
Jan 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.